Share
Other content recommended for you
- Introducing the non-invasive prenatal testing for detection of Down syndrome in China: a cost-effectiveness analysis
- Unconditional access to non-invasive prenatal testing (NIPT) for adult-onset conditions: a defence
- Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down’s syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units
- Mainstreaming genetics into Italian prenatal care: exploring the future implementation of non-invasive prenatal testing (NIPT) in the Italian National Healthcare System using stakeholder interviews
- Non-invasive prenatal testing in mitigating concerns from invasive prenatal diagnostic testing: retrospective assessment of utility in an academic healthcare system in the US
- Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysis
- Should pregnant women be charged for non-invasive prenatal screening? Implications for reproductive autonomy and equal access
- Introducing the non-invasive prenatal test for trisomy 21 in Belgium: a cost-consequences analysis
- Ethics of routine: a critical analysis of the concept of ‘routinisation’ in prenatal screening
- Preserving women’s reproductive autonomy while promoting the rights of people with disabilities?: the case of Heidi Crowter and Maire Lea-Wilson in the light of NIPT debates in England, France and Germany